S Moro

Novel strategies for the design of new potent and selective human A3 receptor antagonists: an update.

S. Moro, G. Spalluto, F. Deflorian, 2006, Current medicinal chemistry.

Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

S. Moro, K. Jacobson, A. IJzerman, 1998, Journal of medicinal chemistry.

Role of the extracellular loops of G protein-coupled receptors in ligand recognition: a molecular modeling study of the human P2Y1 receptor.

S. Moro, K. Jacobson, C. Hoffmann, 1999, Biochemistry.

Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.

S. Moro, K. Jacobson, X. Ji, 1999, Journal of medicinal chemistry.

Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen.

S. Moro, K. Klotz, G. Spalluto, 2000, Journal of medicinal chemistry.

Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model.

S. Moro, K. Jacobson, A. V. van Rhee, 1998, Journal of medicinal chemistry.